多学科胸部肿瘤项目中肺癌筛查的障碍:偶然性肺结节项目的影响
该研究纳入2015至2023年多学科胸部肿瘤项目的1904例肺癌患者,分析肺癌筛查(LCS)障碍及偶然性肺结节(IPN)项目的作用。结果显示,合格未筛查者占41.4%,不合格者占52.2%,因资格标准被排除的患者多于合格但未筛查者,IPN项目缓解了两类障碍。
要点
- 合格未筛查者41.4%,不合格者52.2%,因资格标准被排除者多于合格未筛查者。
- 合格未筛查者中42%经IPN项目诊断,不合格者中46%经IPN项目诊断。
- 合格未筛查者诊断前12至36个月有临床就诊者占33%。
核心结论
- 在该社区队列中,筛查改善了生存,资格标准排除的患者多于合格但未筛查者,IPN项目缓解了两类障碍。
研究设计与样本
- 研究为多学科胸部肿瘤项目队列,纳入2015至2023年入组的1904例肺癌患者,将其分为已筛查、合格未筛查、不合格三类,并将未筛查队列按是否暴露于IPN项目进一步分类,比较各组肺癌结局。
主要发现
- 1904例患者中,已筛查者占6.4%,合格未筛查者占41.4%,不合格者占52.2%。
- 合格未筛查者中42%(全队列17%)经IPN项目诊断,不合格者中46%(全队列24%)经IPN项目诊断。
- 合格未筛查非IPN队列中33%在诊断前12至36个月有临床就诊。
- 不合格者中28%年龄不合格,20%从未吸烟,20.5%吸烟史少于20包年,32.5%戒烟时间过长。
- 三组五年总生存率分别为已筛查77%(95%CI 73-89)、合格未筛查45%(41-49)、不合格50%(46-54),P<0.0001。
关键数值与推荐
- 合格未筛查队列中,IPN队列与非IPN队列五年总生存率分别为61%(55-68)与35%(30-39)。
- 不合格队列中,IPN队列与非IPN队列五年总生存率分别为60%(55-67)与42%(37-47)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Lung cancer screening (LCS) reduces mortality; nevertheless, its adoption has been slow, and some people who develop lung cancer are ineligible. Incidental pulmonary nodule (IPN) programs can also detect lung cancer early. We quantified the barriers to LCS and the impact of the IPN program. METHODS: We categorized patients with lung cancer enrolled in a Multidisciplinary Thoracic Oncology Program from 2015 to 2023 as screened, unscreened, eligible, or ineligible for LCS. We further categorized the unscreened cohorts according to their exposure to IPN programs. We compared the lung cancer outcomes between the groups. RESULTS: Of the 1904 patients, 6.4%, 41.4%, and 52.2% were screened, eligible unscreened, and ineligible, respectively; 42% of the eligible unscreened (17% of the whole cohort) and 46% of the ineligible cohort (24% of the whole cohort) were diagnosed through the IPN program. Thirty-three percent of the eligible unscreened non-IPN cohort had clinical encounters 12 to 36 months before diagnosis. Among the ineligible participants, 28% were age-ineligible, 20% had never smoked, 20.5% had a less than 20-pack-year history, and 32.5% had an excessive quitting duration. The five-year overall survival rates were 77% (95% confidence interval: 73-89), 45% (41-49), and 50% (46-54), respectively (p < 0.0001). With the eligible unscreened as a reference, the adjusted hazard ratios were 0.36 (0.23-0.54) and 0.87 (0.75-1.01) for the screened and ineligible cohorts. Five-year overall survival was 61% (55-68) versus 35% (30-39) and 60% (55-67) versus 42% (37-47) among IPN versus non-IPN cohorts of eligible unscreened and ineligible cohorts, respectively. CONCLUSIONS: Screening improved the survival in this community-based cohort. The eligibility criteria excluded more patients than the failure to screen eligible patients. The IPN program alleviated both barriers.
引用
- Liao W, Ray MA, Patel A, et al. Barriers to Lung Cancer Screening in a Multi-Disciplinary Thoracic Oncology Program Cohort: Effects of an Incidental Pulmonary Nodule Program. J Thorac Oncol. 2025. PMID: 39892668. doi:10.1016/j.jtho.2025.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。